Insulin resistance promotes hepatic de novo lipogenesis by activating sterol regulatory element–binding protein 1 and lipid accumulation by inactivating Forkhead box protein A2, a transcription factor that promotes fatty acid oxidation in the liver (28, 29). Here, FOXA2 is linked to Insulin resistance.